Sri Harsha Tella, MD, FACP is a medical oncologist and hematologist with a special interest in precision oncology, gastrointestinal malignancies, neuroendocrine tumors, and benign hematological conditions. He is also specialty trained in endocrinology with a special focus on endocrine malignancies, neuroendocrine tumors, and oncologic endocrinology.

Dr. Tella believes in patient-centric care and is inspired by his patients’ resilience and positive mindsets even in the face of extraordinary challenges that many encounter while fighting cancer. In his view, it is his career in cancer care has definitely shaped who he is today and he believes it’s a privilege to take care of people who battle cancer.

In addition to his clinical activities, Dr. Tella is active in both research and education. Dr. Tella’s research focuses on novel drug therapy development. During his tenure at the National Institutes of Health (NIH) and Mayo Clinic, he wrote clinical trial protocols for novel drug therapies in endocrine and gastrointestinal malignancies. His research has been published in high impact journals such as the Lancet Oncology, Journal of National Comprehensive Care Network (JNCCN), The Oncologist, Journal of Clinical Endocrinology and Metabolism (JCEM) among others.

Dr. Tella has been the recipient of several coveted nationally recognized awards, including the American Society of Clinical Oncology (ASCO) merit awards, Minnesota Society of Clinical Oncology outstanding fellow award for research, the Endocrine Society- Young Investigator Award/outstanding research award, Raisz-Drezner award from the American Society of Bone and Mineral Research (ASBMR), and Mayo Clinic Clinical and Translational Science Award (CTSA) grant among several others.

Dr. Tella is very active in American Society of Clinical Oncology where he serves as a member of the ASCO-Self Evaluation Program (SEP) Item writing task force contributing to Oncology fellows’ education. He also served as Assistant Professor of Oncology and Medicine at Mayo Alix School of Medicine during his tenure at Mayo Clinic.